Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saffron Naturele Products, operating primarily under its flagship brand Advancells, is a leading Indian biotechnology and regenerative medicine company. Founded in 2004 and headquartered in Noida, the company specializes in the research-oriented development, processing, and production of autologous stem cells, primary cells, and exosomes. Saffron Naturele Products provides customized stem cell processing services for a wide range of degenerative, chronic, and age-related conditions, including neurodegenerative disorders, orthopedic conditions, and autoimmune diseases. Additionally, through its various divisions like Kosheeka and Advancells Diagnostics, the company manufactures and supplies high-quality primary cells, cell culture media, and point-of-care diagnostic and therapeutic kits, such as Viral Transport Medium (VTM) kits, Platelet-Rich Plasma (PRP) kits, and Bone Marrow Aspirate Concentrate (BMC) kits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saffron Naturele Products.